Escitalopram’s Efficacy in American Males with Depression and Substance Abuse: A Cohort Study
Reading Time: 2 minutes Introduction Depression and substance abuse often co-occur, presenting a complex challenge in clinical settings. This dual diagnosis requires a nuanced approach to treatment, balancing the management of mood disorders with the need to address substance dependency. Escitalopram, a selective serotonin reuptake inhibitor (SSRI), has been widely used for treating depression. However, its effectiveness in American males with co-existing substance abuse issues remains under-explored. This article delves into a recent cohort study that evaluates the efficacy of escitalopram in managing dual diagnosis cases among American males. Study Design and Methodology The cohort study involved 250 American males aged between 18 and...


